Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Approaching endocrine symptoms and hormone feedback loops

Endocrinology and metabolism · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Shock with vomiting or hyperkalaemia, severe hypo- or hyperglycaemia with ketones or altered consciousness, profound sodium disturbance with seizure, severe calcium disturbance with arrhythmia, new visual loss with sudden headache, thyroid-related hyperthermia and delirium, or hypothermia with bradycardia requires immediate ABCDE care. Take useful endocrine samples when this causes no delay, but do not withhold hydrocortisone, glucose, fluids or other life-saving treatment while waiting for hormone results.

Synopsis

Convert non-specific symptoms into an anatomical endocrine hypothesis, interpret paired hormones through feedback physiology, and recognise results or presentations that need immediate treatment or specialist escalation.

  • Endocrine symptoms such as fatigue, weight change, thirst, menstrual disturbance and palpitations are common; specificity comes from tempo, associated signs, medicines and a coherent physiological pattern.
  • Interpret a target-gland hormone with its controlling hormone whenever the axis permits: an isolated number often cannot distinguish primary gland disease from hypothalamic or pituitary disease.
  • In primary target-gland failure the end hormone is low and the trophic hormone usually rises; in central failure the trophic hormone is low or inappropriately normal for the low end hormone.
  • Autonomous end-hormone excess usually suppresses its upstream controller, whereas central trophic-hormone excess produces an unsuppressed or raised controller despite a high target hormone.
  • Time, posture, fasting, sleep, menstrual phase, pregnancy, acute illness and recent exercise can change a valid result without any gland being diseased.
  • Ask about every glucocorticoid route, biotin supplements, dopamine-active medicines, opioids, lithium, amiodarone and sex hormones before interpreting cortisol, thyroid, prolactin or gonadal axes.
  • An apparently normal controlling hormone may be pathological when the end hormone is abnormal: normal TSH with low free T4 can be inappropriately normal in central hypothyroidism.
  • Confirm biochemical disease before searching for a small pituitary or adrenal lesion, except when acute mass effect, apoplexy, cancer or another structural emergency drives imaging first.
  • Interpret results with the laboratory's current assay, reference interval, sampling protocol and endocrine advice because reference ranges and dynamic decision limits are method-specific.

Key red flags

Central endocrine failure

A low end hormone with a low or merely normal trophic hormone is discordant and can indicate hypothalamic or pituitary disease, particularly when several axes or visual symptoms coexist.

Pituitary mass effect

Progressive visual-field loss, diplopia, severe headache, ophthalmoplegia or multiple pituitary deficits needs urgent pituitary assessment; abrupt headache and visual change raises apoplexy.

Adrenal crisis phenotype

Hypotension, vomiting, abdominal pain, fever, hyponatraemia, hyperkalaemia or hypoglycaemia in someone with steroid exposure or autoimmune disease justifies immediate hydrocortisone and resuscitation.

Investigation priorities

01
Paired TSH and free T4First step

Assess the thyroid axis and distinguish primary thyroid dysfunction from a potentially central pattern.

Management branches

First encounterBuild an axis hypothesis

Non-specific symptoms raise the possibility of endocrine disease.

  1. Define tempo, episodic triggers, weight and fluid balance, reproductive symptoms, family syndromes and every prescribed, injected, inhaled, topical and non-prescription hormone-active product.
  2. Examine physiology and targeted signs, separating an acutely unstable presentation from a stable outpatient question before ordering broad tests.
  3. Choose the smallest set of paired hormones and safety bloods that can answer the proposed axis and important alternatives, documenting sampling conditions.
  4. Interpret results against pre-test probability and feedback physiology, then decide whether to repeat, dynamically test, image or refer rather than expanding indiscriminately.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG145 thyroid diseasePaired thyroid testing, acute-illness cautions, biotin and repeat-testing principles.
  • NICE NG243 adrenal insufficiencyRecognition, morning cortisol testing, emergency treatment and referral.
  • Society for Endocrinology clinical guidanceUK endocrine emergency frameworks across adrenal, pituitary, sodium and calcium disorders.
  • NICE NG132 primary hyperparathyroidismRepeat calcium, PTH interpretation and specialist assessment.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom